NEUCA : strengthens its relationship with pharmacies and increases revenues

NEUCA recorded growth in revenue of 7% - up to PLN 5.59 billion in three quarters of 2017. At the same time, the Group strengthened its market position, reaching almost 29% of the pharmaceutical wholesale market share, compared to 28% in the first nine months in 2016.

In the first nine months of 2017, the Company generated a net profit of PLN 68.5 million excluding one-off events, i.e. 19% less than in the corresponding period. The decline in profit was driven by changes in the market strategies adopted by the producers as a result of their consolidation and the new legal environment. After nine months, the Group fulfilled 69% of its financial plan with an estimated net profit of PLN 100 million, excluding one-off events. In own product segment, NEUCA generated a net profit of PLN 21.2 million in the first nine months of 2017, that is 10% more than in the same period a year earlier. Own products sales to pharmacies increased by 12% in the first nine months to almost PLN 89 million.

NEUCA is constantly developing and investing in the area of patient businesses. At the end of September 2017, Świat Zdrowia outpatient clinics network had 63 units with access to144 thousand patients. At the same time, NEUCA conducted intensive work on the clinical trial segment, particularly in the field of innovative medicines.

« Back to list